- Home
- BIAF vs HTCR Comparison
BIAF vs HTCR Comparison
Compare BIAF & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIAF | HTCR |
|---|---|---|
| Founded | 2014 | 2009 |
| Country | United States | Japan |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 4.4M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | BIAF | HTCR |
|---|---|---|
| Price | $1.92 | $2.87 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 363.4K | 56.2K |
| Earning Date | 05-14-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 87.84% |
| EPS Growth | N/A | ★ 414.29 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | ★ $30,407,229.00 |
| Revenue This Year | $20.95 | $123.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ 39.19 |
| 52 Week Low | $0.20 | $0.15 |
| 52 Week High | $13.50 | $3.97 |
Technical Indicators
Market Signals| Indicator | BIAF | HTCR |
|---|---|---|
| Relative Strength Index (RSI) | 37.73 | 50.81 |
| Support Level | $1.23 | $2.85 |
| Resistance Level | $3.58 | $3.85 |
| Average True Range (ATR) | 0.23 | 0.33 |
| MACD | -0.05 | -0.14 |
| Stochastic Oscillator | 8.91 | 8.11 |
Price Performance
Historical ComparisonAbout BIAF bioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.